Published in J Bacteriol on April 01, 2006
Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA (2006) 4.53
Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev (2009) 4.11
Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol (2006) 2.42
Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol Microbiol (2006) 2.17
BdlA, a chemotaxis regulator essential for biofilm dispersion in Pseudomonas aeruginosa. J Bacteriol (2006) 1.82
Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization. Infect Immun (2008) 1.66
Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol (2008) 1.64
Noninvasive in vivo optical detection of biofilm in the human middle ear. Proc Natl Acad Sci U S A (2012) 1.63
The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog (2010) 1.57
Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms. J Bacteriol (2006) 1.51
Diguanylate cyclase NicD-based signalling mechanism of nutrient-induced dispersion by Pseudomonas aeruginosa. Mol Microbiol (2014) 1.46
Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. MBio (2013) 1.40
The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun (2009) 1.36
The phosphodiesterase DipA (PA5017) is essential for Pseudomonas aeruginosa biofilm dispersion. J Bacteriol (2012) 1.34
Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol (2012) 1.33
Non-invasive optical interferometry for the assessment of biofilm growth in the middle ear. Biomed Opt Express (2010) 1.29
Sticky situations: key components that control bacterial surface attachment. J Bacteriol (2012) 1.27
Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease. J Infect Dis (2010) 1.25
Formation of Streptococcus pneumoniae non-phase-variable colony variants is due to increased mutation frequency present under biofilm growth conditions. J Bacteriol (2008) 1.20
Early biofilm formation on microtiter plates is not correlated with the invasive disease potential of Streptococcus pneumoniae. Microb Pathog (2010) 1.11
Characterization of two host-specific genes, mannose-sensitive hemagglutinin (mshA) and uridyl phosphate dehydrogenase (UDPDH) that are involved in the Vibrio fischeri-Euprymna tasmanica mutualism. FEMS Microbiol Lett (2009) 1.11
Microcolony formation by the opportunistic pathogen Pseudomonas aeruginosa requires pyruvate and pyruvate fermentation. Mol Microbiol (2012) 1.09
Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms. MBio (2013) 1.08
Dispersal of biofilms by secreted, matrix degrading, bacterial DNase. PLoS One (2010) 1.07
SagS contributes to the motile-sessile switch and acts in concert with BfiSR to enable Pseudomonas aeruginosa biofilm formation. J Bacteriol (2011) 1.05
Bacterial biofilms in the upper airway - evidence for role in pathology and implications for treatment of otitis media. Paediatr Respir Rev (2012) 1.05
The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state. Appl Environ Microbiol (2014) 1.04
The LuxS-dependent quorum-sensing system regulates early biofilm formation by Streptococcus pneumoniae strain D39. Infect Immun (2011) 1.02
Characterization of in vitro biofilm-associated pneumococcal phase variants of a clinically relevant serotype 3 clone. J Clin Microbiol (2006) 1.01
Biofilm formation in Streptococcus pneumoniae. Microb Biotechnol (2011) 0.98
Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae. Infect Immun (2013) 0.98
Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease. Front Cell Infect Microbiol (2015) 0.97
Characterization and comparison of biofilm development by pathogenic and commensal isolates of Histophilus somni. J Bacteriol (2007) 0.96
The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm tolerance. J Bacteriol (2012) 0.96
The impact of the competence quorum sensing system on Streptococcus pneumoniae biofilms varies depending on the experimental model. BMC Microbiol (2011) 0.92
Large scale genomic analysis shows no evidence for pathogen adaptation between the blood and cerebrospinal fluid niches during bacterial meningitis. Microb Genom (2017) 0.91
Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization. Front Cell Infect Microbiol (2014) 0.90
Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection. Infect Immun (2014) 0.90
Antimicrobial tolerance of Pseudomonas aeruginosa biofilms is activated during an early developmental stage and requires the two-component hybrid SagS. J Bacteriol (2013) 0.90
PAS domain residues and prosthetic group involved in BdlA-dependent dispersion response by Pseudomonas aeruginosa biofilms. J Bacteriol (2012) 0.90
Effect of biofilm formation by Pseudoalteromonas spongiae on induction of larval settlement of the polychaete Hydroides elegans. Appl Environ Microbiol (2007) 0.90
Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera. BMC Microbiol (2011) 0.88
Regulation of virulence gene expression resulting from Streptococcus pneumoniae and nontypeable Haemophilus influenzae interactions in chronic disease. PLoS One (2011) 0.87
Contribution of serotype and genetic background to biofilm formation by Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis (2010) 0.86
Future perspective on host-pathogen interactions during bacterial biofilm formation within the nasopharynx. Future Microbiol (2012) 0.85
Mutations in pneumococcal cpsE generated via in vitro serial passaging reveal a potential mechanism of reduced encapsulation utilized by a conjunctival isolate. J Bacteriol (2015) 0.85
Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization. Clin Vaccine Immunol (2015) 0.85
In VitroStreptococcus pneumoniae Biofilm Formation and In Vivo Middle Ear Mucosal Biofilm in a Rat Model of Acute Otitis Induced by S. pneumoniae. Clin Exp Otorhinolaryngol (2012) 0.84
Pronounced metabolic changes in adaptation to biofilm growth by Streptococcus pneumoniae. PLoS One (2014) 0.83
BIOLOGICAL PROPERTIES (IN VITRO) EXHIBITED BY FREE-LIVING AND SYMBIOTIC VIBRIO ISOLATES. Vie Milieu Paris (2009) 0.81
Insights into xanthomonas axonopodis pv. citri biofilm through proteomics. BMC Microbiol (2013) 0.80
Control of Biofilms with the Fatty Acid Signaling Molecule cis-2-Decenoic Acid. Pharmaceuticals (Basel) (2015) 0.78
Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model. Antimicrob Agents Chemother (2013) 0.77
The behaviour of both Listeria monocytogenes and rat ciliated ependymal cells is altered during their co-culture. PLoS One (2010) 0.77
Biofilm-specific extracellular matrix proteins of nontypeable Haemophilus influenzae. Pathog Dis (2014) 0.76
Differential protein expression in Streptococcus uberis under planktonic and biofilm growth conditions. Appl Environ Microbiol (2010) 0.76
Proteomics dedicated to biofilmology: What have we learned from a decade of research? Med Microbiol Immunol (2015) 0.75
The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients. BMC Microbiol (2017) 0.75
Implantable Device-Related Infection. Shock (2016) 0.75
RpoN (σ(54)) is required for floc formation but not for extracellular polysaccharide biosynthesis in a floc-forming Aquincola tertiaricarbonis strain. Appl Environ Microbiol (2017) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem (1977) 36.95
Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science (2001) 21.99
Microbial biofilms. Annu Rev Microbiol (1995) 21.58
Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev (2002) 17.58
Biofilm formation as microbial development. Annu Rev Microbiol (2000) 13.33
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature (2000) 10.32
Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev (2000) 9.83
Biofilms as complex differentiated communities. Annu Rev Microbiol (2002) 9.31
Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol (2001) 7.97
Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol (1995) 7.32
PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. Ann Intern Med (1964) 7.18
Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol (2002) 6.98
Gene expression in Pseudomonas aeruginosa biofilms. Nature (2001) 6.70
Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev (1998) 6.28
Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell (2002) 4.94
A component of innate immunity prevents bacterial biofilm development. Nature (2002) 4.73
A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med (1992) 4.60
Biofilms, the customized microniche. J Bacteriol (1994) 4.33
Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J Bacteriol (1999) 4.26
Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis (1998) 4.12
Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun (1992) 3.80
The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest (2003) 3.46
ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem (2000) 3.42
Global gene expression in Escherichia coli biofilms. Mol Microbiol (2003) 3.33
Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro. J Exp Med (1950) 3.24
Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl Environ Microbiol (1995) 3.14
Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol Microbiol (1996) 3.11
Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA (2002) 2.96
Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol Microbiol (1999) 2.95
Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun (2000) 2.91
alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface. Mol Microbiol (2001) 2.81
Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J Bacteriol (2004) 2.74
Microscopic examination of natural sessile bacterial populations from an alpine stream. Can J Microbiol (1977) 2.70
Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun (2001) 2.55
Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med (1974) 2.46
Ten-year review of otitis media pathogens. Pediatr Infect Dis J (1992) 2.36
The use of Sorbarod biofilms to study the antimicrobial susceptibility of a strain of Streptococcus pneumoniae. J Antimicrob Chemother (1997) 2.34
Characterization of phenotypic changes in Pseudomonas putida in response to surface-associated growth. J Bacteriol (2001) 2.33
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
Experimental reproducibility in flow-chamber biofilms. Microbiology (2000) 2.28
Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology (2005) 2.24
Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. Br Med J (Clin Res Ed) (1985) 1.98
Induction of rapid detachment in Shewanella oneidensis MR-1 biofilms. J Bacteriol (2005) 1.97
Prevention and control of bacterial infections associated with medical devices. ASAIO J (1993) 1.88
The microbiology of otitis media. Pediatr Infect Dis J (1989) 1.82
Characterization of temporal protein production in Pseudomonas aeruginosa biofilms. J Bacteriol (2005) 1.81
The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J Bacteriol (2001) 1.77
Digital image analysis of growth and starvation responses of a surface-colonizing Acinetobacter sp. J Bacteriol (1995) 1.76
Glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pneumoniae is a surface-displayed plasminogen-binding protein. Infect Immun (2004) 1.74
Spontaneous sequence duplication within an open reading frame of the pneumococcal type 3 capsule locus causes high-frequency phase variation. Mol Microbiol (2001) 1.73
Characterization, distribution, and expression of novel genes among eight clinical isolates of Streptococcus pneumoniae. Infect Immun (2006) 1.55
Behaviour and developmental effects of otitis media with effusion into the teens. Arch Dis Child (2001) 1.50
Gene expression in Pseudomonas aeruginosa: evidence of iron override effects on quorum sensing and biofilm-specific gene regulation. J Bacteriol (2001) 1.47
The genomics and proteomics of biofilm formation. Genome Biol (2003) 1.43
The impact of otitis media. Pediatr Infect Dis J (1989) 1.39
Streptococcus mutans surface alpha-enolase binds salivary mucin MG2 and human plasminogen. Infect Immun (2004) 1.32
Differential protein expression in phenotypic variants of Streptococcus pneumoniae. Infect Immun (2000) 1.32
Effects of carbon and oxygen limitations and calcium concentrations on biofilm removal processes. Biotechnol Bioeng (1991) 1.31
Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol (2004) 1.28
Pneumococcal disease and the role of conjugate vaccines. Microb Drug Resist (1999) 1.27
Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis (2000) 1.23
Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae. J Infect Dis (1991) 1.23
Overall cost in the treatment of otitis media. Pediatr Infect Dis J (1997) 1.16
Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis. J Infect Dis (1997) 1.13
Pneumolysin in pneumococcal adherence and colonization. Microb Pathog (1998) 1.10
Growth and comparative physiology of Klebsiella oxytoca attached to granular activated carbon particles and in liquid media. Microb Ecol (1988) 1.10
Otitis media: back to basics. Pediatr Infect Dis J (1998) 1.00
Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol (2002) 6.98
Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA (2006) 4.53
Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell (2000) 4.45
Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science (1998) 3.83
Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: insights into the pneumococcal supragenome. J Bacteriol (2007) 3.62
Enteropathogenic Escherichia coli enteritis: evaluation of the gnotobiotic piglet as a model of human infection. Gut (1985) 3.43
Characterization and modeling of the Haemophilus influenzae core and supragenomes based on the complete genomic sequences of Rd and 12 clinical nontypeable strains. Genome Biol (2007) 3.29
Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA (2002) 2.96
Transmission thresholds for dengue in terms of Aedes aegypti pupae per person with discussion of their utility in source reduction efforts. Am J Trop Med Hyg (2000) 2.95
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J (2006) 2.94
Insights into the genome of large sulfur bacteria revealed by analysis of single filaments. PLoS Biol (2007) 2.69
Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species. Genome Biol (2010) 2.60
Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother (2004) 2.51
An asymmetric model for the nucleosome: a binding site for linker histones inside the DNA gyres. Science (1996) 2.30
The checkpoint control for anaphase onset does not monitor excess numbers of spindle poles or bipolar spindle symmetry. J Cell Sci (1997) 2.11
Individualized managing strategies of aggressive angiomyxoma of female genital tract and pelvis. Eur J Surg Oncol (2013) 2.02
Prevalence of obesity in American Indians and Alaska Natives. Am J Clin Nutr (1991) 1.92
BdlA, a chemotaxis regulator essential for biofilm dispersion in Pseudomonas aeruginosa. J Bacteriol (2006) 1.82
Characterization of temporal protein production in Pseudomonas aeruginosa biofilms. J Bacteriol (2005) 1.81
A versatile microporation technique for the transfection of cultured CNS neurons. J Neurosci Methods (1999) 1.80
Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension (1991) 1.78
Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol (2000) 1.76
Effect of new federal gun-control law on physicians. Can Med Assoc J (1978) 1.69
Bacterial plurality as a general mechanism driving persistence in chronic infections. Clin Orthop Relat Res (2005) 1.67
Generation of genic diversity among Streptococcus pneumoniae strains via horizontal gene transfer during a chronic polyclonal pediatric infection. PLoS Pathog (2010) 1.66
Biofilms and chronic infections. JAMA (2008) 1.65
Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol (2008) 1.64
The pathogenesis of Yersinia enterocolitica infection in gnotobiotic piglets. J Med Microbiol (1985) 1.64
Characterization of an enteropathogenic bovine calicivirus representing a potentially new calicivirus genus. J Virol (2002) 1.57
The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog (2010) 1.57
Characterization, distribution, and expression of novel genes among eight clinical isolates of Streptococcus pneumoniae. Infect Immun (2006) 1.55
Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms. J Bacteriol (2006) 1.51
A novel signaling network essential for regulating Pseudomonas aeruginosa biofilm development. PLoS Pathog (2009) 1.49
Diguanylate cyclase NicD-based signalling mechanism of nutrient-induced dispersion by Pseudomonas aeruginosa. Mol Microbiol (2014) 1.46
Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report. J Bone Joint Surg Am (2008) 1.46
Multiple regions of MAP kinase phosphatase 3 are involved in its recognition and activation by ERK2. J Biol Chem (2000) 1.45
Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol (1983) 1.41
Isoetharine versus albuterol for acute asthma: greater immediate effect, but more side effects. Am J Med (1996) 1.41
Direct evidence of bacterial biofilms in otitis media. 2001. Laryngoscope (2015) 1.41
Thrombolytic therapy in pulmonary embolism. Ir Med J (2010) 1.40
Identification, distribution, and expression of novel genes in 10 clinical isolates of nontypeable Haemophilus influenzae. Infect Immun (2005) 1.39
Patient satisfaction with teleoncology: a pilot study. Telemed J (1995) 1.35
Molecular and imaging techniques for bacterial biofilms in joint arthroplasty infections. Clin Orthop Relat Res (2005) 1.34
The phosphodiesterase DipA (PA5017) is essential for Pseudomonas aeruginosa biofilm dispersion. J Bacteriol (2012) 1.34
Successful identification of pathogens by polymerase chain reaction (PCR)-based electron spray ionization time-of-flight mass spectrometry (ESI-TOF-MS) in culture-negative periprosthetic joint infection. J Bone Joint Surg Am (2012) 1.34
Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy. J Neurol Sci (2007) 1.31
Toxicology of Abate in volunteers. Arch Environ Health (1967) 1.29
The novel two-component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsmZ through CafA. J Bacteriol (2010) 1.29
Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. Expert Opin Ther Targets (2010) 1.29
A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides. Am J Med (1981) 1.28
The distributed genome hypothesis as a rubric for understanding evolution in situ during chronic bacterial biofilm infectious processes. FEMS Immunol Med Microbiol (2010) 1.27
Sticky situations: key components that control bacterial surface attachment. J Bacteriol (2012) 1.27
Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother (2006) 1.27
Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743. ACS Chem Biol (2011) 1.26
Diagnosis of periprosthetic joint infection. J Arthroplasty (2013) 1.24
The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection. BMC Infect Dis (2013) 1.23
Formation of Streptococcus pneumoniae non-phase-variable colony variants is due to increased mutation frequency present under biofilm growth conditions. J Bacteriol (2008) 1.20
The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg (2007) 1.20
Extensive genomic plasticity in Pseudomonas aeruginosa revealed by identification and distribution studies of novel genes among clinical isolates. Infect Immun (2006) 1.20
Chronic surgical site infection due to suture-associated polymicrobial biofilm. Surg Infect (Larchmt) (2009) 1.19
Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates. BMC Genomics (2011) 1.18
Physiology of Pseudomonas aeruginosa in biofilms as revealed by transcriptome analysis. BMC Microbiol (2010) 1.16
Engineering approaches for the detection and control of orthopaedic biofilm infections. Clin Orthop Relat Res (2005) 1.15
Mucosal biofilm formation on middle-ear mucosa in a nonhuman primate model of chronic suppurative otitis media. Laryngoscope (2005) 1.15
Pan-genome analysis provides much higher strain typing resolution than multi-locus sequence typing. Microbiology (2009) 1.14
Adenoid reservoir for pathogenic biofilm bacteria. J Clin Microbiol (2011) 1.14
New methods for the detection of orthopedic and other biofilm infections. FEMS Immunol Med Microbiol (2011) 1.14
Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J Bacteriol (2008) 1.13
Streptococcus durans: an unexpected enteropathogen of foals. J Infect Dis (1984) 1.13
Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol (2012) 1.13
Strain-specific virulence phenotypes of Streptococcus pneumoniae assessed using the Chinchilla laniger model of otitis media. PLoS One (2008) 1.12
The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg (2004) 1.12
Early biofilm formation on microtiter plates is not correlated with the invasive disease potential of Streptococcus pneumoniae. Microb Pathog (2010) 1.11
Early amino-acid administration improves preterm infant weight. J Perinatol (2009) 1.11
Unique challenges of obtaining regulatory approval for a multicenter protocol to study the genetics of RRP and suggested remedies. Otolaryngol Head Neck Surg (2006) 1.11
Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome. Br J Cancer (2005) 1.11
Comparative supragenomic analyses among the pathogens Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae using a modification of the finite supragenome model. BMC Genomics (2011) 1.11
Comparison of continuation rates for hormonal contraception among adolescents. J Pediatr Adolesc Gynecol (1999) 1.10
Microcolony formation by the opportunistic pathogen Pseudomonas aeruginosa requires pyruvate and pyruvate fermentation. Mol Microbiol (2012) 1.09
Genome of alkaliphilic Bacillus pseudofirmus OF4 reveals adaptations that support the ability to grow in an external pH range from 7.5 to 11.4. Environ Microbiol (2011) 1.09
Production and processing of erythropoietin receptor transcripts in brain. Brain Res Mol Brain Res (2000) 1.09
Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates. Pediatr Cardiol (2007) 1.09
Arbovirus studies in the Ohio-Mississippi Basin, 1964-1967. VII. Lone Star virus, a hitherto unknown agent isolated from the tick Amblyomma americanum (Linn). Am J Trop Med Hyg (1969) 1.09
Deletion and acquisition of genomic content during early stage adaptation of Pseudomonas aeruginosa to a human host environment. Environ Microbiol (2012) 1.09
Dispersion by Pseudomonas aeruginosa requires an unusual posttranslational modification of BdlA. Proc Natl Acad Sci U S A (2012) 1.08